BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34653723)

  • 1. Impact of allogeneic feline uterine-derived mesenchymal stromal cell intravenous treatment on renal function of nephrectomized cats with chronic kidney disease.
    Zacharias S; Welty MB; Sand TT; Black LL
    Res Vet Sci; 2021 Dec; 141():33-41. PubMed ID: 34653723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats.
    Quimby JM; Webb TL; Randall E; Marolf A; Valdes-Martinez A; Dow SW
    J Feline Med Surg; 2016 Feb; 18(2):165-71. PubMed ID: 25784460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies.
    Quimby JM; Webb TL; Habenicht LM; Dow SW
    Stem Cell Res Ther; 2013 Apr; 4(2):48. PubMed ID: 23632128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified methods for estimating glomerular filtration rate in cats and for detection of cats with low or borderline glomerular filtration rate.
    Paepe D; Lefebvre HP; Concordet D; van Hoek I; Croubels S; Daminet S
    J Feline Med Surg; 2015 Oct; 17(10):889-900. PubMed ID: 25518848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial renal infusion of autologous mesenchymal stem cells for treatment of chronic kidney disease in cats: Phase I clinical trial.
    Thomson AL; Berent AC; Weisse C; Langston CE
    J Vet Intern Med; 2019 May; 33(3):1353-1361. PubMed ID: 30924554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of amniotic membrane-derived multipotent cells ameliorates and delays the progression of chronic kidney disease in cats.
    Vidane AS; Pinheiro AO; Casals JB; Passarelli D; Hage M; Bueno RS; Martins DS; Ambrósio CE
    Reprod Domest Anim; 2017 Apr; 52 Suppl 2():316-326. PubMed ID: 27774657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between serum symmetric dimethylarginine concentration and glomerular filtration rate in cats.
    Braff J; Obare E; Yerramilli M; Elliott J; Yerramilli M
    J Vet Intern Med; 2014; 28(6):1699-701. PubMed ID: 25272985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum creatinine, point-of-care symmetric dimethylarginine and renal imaging with glomerular filtration rate measured by renal scintigraphy in healthy and early chronic kidney diseased cats.
    da Cruz Schaefer G; de Mattos Brose M; Herrera Becerra JR; Bernhardt Rovaris I; Peixoto da Silva Mello F; Schneck Simão B; de Faria Valle S; Poletto Ferreira M; Vieira Amorim da Costa F
    Vet Res Commun; 2023 Dec; 47(4):1845-1859. PubMed ID: 37133704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical validation of a human particle-enhanced nephelometric assay for cystatin C measurement in feline serum and urine.
    Ghys LF; Meyer E; Paepe D; Delanghe J; Daminet S
    Vet Clin Pathol; 2014 Jun; 43(2):226-34. PubMed ID: 24773065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine kidney variables, glomerular filtration rate and urinary cystatin C in cats with diabetes mellitus, cats with chronic kidney disease and healthy cats.
    Paepe D; Ghys LF; Smets P; Lefebvre HP; Croubels S; Daminet S
    J Feline Med Surg; 2015 Oct; 17(10):880-8. PubMed ID: 25425599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated measurements of renal function in evaluating its decline in cats.
    Finch NC; Syme HM; Elliott J
    J Feline Med Surg; 2018 Dec; 20(12):1144-1148. PubMed ID: 29451445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the single blood sample method to estimate feline glomerular filtration rate in a clinically relevant situation.
    Katayama M; Sasaki A; Takayasu M; Shimamura S; Uzuka Y; Murayama I; Satoh H; Furuhama K
    J Feline Med Surg; 2013 Dec; 15(12):1119-22. PubMed ID: 23735674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of exposure to microbial ligands, immunosuppressive drugs and chronic kidney disease on endogenous immunomodulatory gene expression in feline adipose-derived mesenchymal stem cells.
    Creamer DG; Schmiedt CW; Bullington AC; Caster CM; Schmiedt JM; Hurley DJ; Berghaus RD
    J Feline Med Surg; 2022 Jun; 24(6):e43-e56. PubMed ID: 35302413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low-dose meloxicam in cats with chronic kidney disease.
    KuKanich K; George C; Roush JK; Sharp S; Farace G; Yerramilli M; Peterson S; Grauer GF
    J Feline Med Surg; 2021 Feb; 23(2):138-148. PubMed ID: 32594827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease.
    Hall JA; Yerramilli M; Obare E; Yerramilli M; Jewell DE
    J Vet Intern Med; 2014; 28(6):1676-83. PubMed ID: 25231385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: a pilot study.
    Quimby JM; Webb TL; Gibbons DS; Dow SW
    J Feline Med Surg; 2011 Jun; 13(6):418-26. PubMed ID: 21334237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).
    Perico N; Remuzzi G; Griffin MD; Cockwell P; Maxwell AP; Casiraghi F; Rubis N; Peracchi T; Villa A; Todeschini M; Carrara F; Magee BA; Ruggenenti PL; Rota S; Cappelletti L; McInerney V; Griffin TP; Islam MN; Introna M; Pedrini O; Golay J; Finnerty AA; Smythe J; Fibbe WE; Elliman SJ; O'Brien T;
    J Am Soc Nephrol; 2023 Oct; 34(10):1733-1751. PubMed ID: 37560967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow-mesenchymal stromal cell infusion in patients with chronic kidney disease: A safety study with 18 months of follow-up.
    Makhlough A; Shekarchian S; Moghadasali R; Einollahi B; Dastgheib M; Janbabaee G; Hosseini SE; Falah N; Abbasi F; Baharvand H; Aghdami N
    Cytotherapy; 2018 May; 20(5):660-669. PubMed ID: 29580865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats.
    Ghys LF; Paepe D; Lefebvre HP; Reynolds BS; Croubels S; Meyer E; Delanghe JR; Daminet S
    J Vet Intern Med; 2016 Jul; 30(4):1074-82. PubMed ID: 27461722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REPEATABILITY AND RELIABILITY OF GLOMERULAR FILTRATION RATE DETERMINATION VIA GAMMA CAMERA UPTAKE OF TC-99M-DTPA IN CATS WITH CHRONIC KIDNEY DISEASE.
    Felumlee AE; Marolf AJ; Randall EK; Bachand AM; Quimby JM
    Vet Radiol Ultrasound; 2017 Jan; 58(1):90-99. PubMed ID: 27774745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.